Sublingual isosorbide dinitrate for the detection of obstruction in hypertrophic cardiomyopathy
Language English Country England, Great Britain Media print-electronic
Document type Journal Article, Research Support, Non-U.S. Gov't
PubMed
21821607
DOI
10.1093/ejechocard/jer115
PII: jer115
Knihovny.cz E-resources
- MeSH
- Administration, Sublingual MeSH
- Cardiomyopathy, Hypertrophic physiopathology MeSH
- Isosorbide Dinitrate * administration & dosage MeSH
- Middle Aged MeSH
- Humans MeSH
- Ventricular Outflow Obstruction complications diagnostic imaging MeSH
- Sensitivity and Specificity MeSH
- Vasodilator Agents * administration & dosage MeSH
- Echocardiography, Stress * MeSH
- Exercise Test MeSH
- Check Tag
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- Isosorbide Dinitrate * MeSH
- Vasodilator Agents * MeSH
AIMS: Hypertrophic cardiomyopathy (HCM) is predominantly associated with left ventricular outflow tract (LVOT) obstruction. The assessment of the obstruction with a provoking test should be a routine part of HCM evaluation. The aim of the study was to determine the utility of a sublingual spray application of isosorbide dinitrate (ISDN) for detection of an obstruction. METHODS AND RESULTS: We have prospectively analysed 77 consecutive HCM patients, measuring the LVOT gradient at rest, using the sublingual spray application of ISDN (2.5 mg; after 2, 5, and 10 min), and with exercise echocardiography. An obstruction was defined as a gradient ≥ 30 mmHg. An obstruction was present in 15 patients (19%) at rest, in 42 patients (55%) after ISDN, and in 55 patients (71%) after exercise. The ISDN test had a sensitivity of 76% and the specificity of 100% relative to exercise echocardiography, while at-rest measurements had a sensitivity of 27% and a specificity of 100%. The chronological difference in the prevalence of obstructions during the ISDN test was statistically significant (P < 0.05); at ISDN plus 2 min, obstructions were seen in only 29 patients (38%, gradient 28.8 ± 25.0 mmHg), however, at ISDN plus 5 and 10 min, obstructions were found in 42 patients (55%, gradient 44.5 ± 39.6 mmHg). CONCLUSION: The ISDN test is a reliable screening method for the detection of an HCM obstruction, however, the measurement should be delayed 5-10 min after the application of ISDN. Patients with negative ISDN tests should undergo exercise echocardiography.
References provided by Crossref.org
How to Treat Obstructions in Patients with Hypertrophic Cardiomyopathy